GlassScriptPhysician profile
Erin M Murray
NPI 1649211053
$4,193.22
in general payments reported to CMS, 2019-2025
24 companies · $540 in 2025
The $540 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $733 · 2022: $605 · 2023: $1,223 · 2024: $1,093 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,855.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Nevro Corp. | $1,098.44 | 2021-2024 | Senza |
| Abbvie INC. | $631.57 | 2023-2025 | |
| Boston Scientific Corporation | $493.80 | 2021-2023 | Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $290.61 | 2025 | Senza, Vyrsa V1 |
| Biohaven Pharmaceuticals, INC. | $260.57 | 2021 | |
| Lilly USA, LLC | $205.53 | 2023-2025 | Emgality, Reyvow |
| Biohaven Pharmaceutical Holding Company LTD. | $204.05 | 2022 | |
| Nalu Medical, INC. | $163.39 | 2021-2024 | Nalu Neurostimulation System |
| Painteq LLC | $161.49 | 2022 | |
| Pfizer INC. | $149.61 | 2021-2025 | |
| Saluda Medical Americas, INC. | $91.07 | 2023-2024 | Evoke, Evoke Scs |
| Sumitomo Pharma America, INC. | $87.88 | 2023-2024 | Aptiom |
| Valinor Pharma, LLC | $53.29 | 2024-2025 | Movantik |
| Stimwave Technologies Incorporated | $45.89 | 2021-2022 | |
| Vertos Medical, INC. | $34.56 | 2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $33.01 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $31.61 | 2024 | Relistor |
| Eisai INC. | $30.87 | 2025 | |
| Livanova USA, INC. | $26.91 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Abbott Laboratories | $24.61 | 2023 | Octrode |
| Relievant Medsystems, INC. | $23.40 | 2021 | |
| Spr Therapeutics, INC | $21.73 | 2023 | Sprint Pns System |
| Biodelivery Sciences International, INC. | $15.48 | 2021 | |
| Curonix LLC | $13.85 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Erin Murray listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.